Ticker ADTX – Aditx – sales, description, marketcap – Tickerday.com

ADTX

Aditx

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 31.82M; Volume: 591.75K; AvgVol 3m: 1.97M; Beta: –;

Cost estimate:

P/E: –; EPS: -0.60; EPS growth quarter/prev quarter: -8.60%;

EPS growth this year: -2.40%; EPS growth past 5 years: ;

EPS ttm: ;

P/S: ; P/B: ; P/Cashflow: ; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: ; ROE – return on equity: ; LT Debt/Equity: ; Total Debt/Equity: ;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 5.90%; Insider Transactions:0.00%;

Institutional Ownership: 1.20%; Institutional Transactions: ;

Data update: 07.10.2020.